Biolase reached $12 million in third-quarter revenue, a year-over-year jump of 26 percent, according to a report the company released Nov. 10.
The company continued to add new customers in the quarter, with 90 percent of its U.S. Waterlase sales from new buyers.
Biolase is anticipating its fourth-quarter revenue to be more than $13 million and its total 2022 revenue to rise at least 20 percent compared to 2021, the release said.